You are here

  • Home
  • Archive
  • Volume 66, Issue 2
  • Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?

Citation Tools

Article menu
Download PDFPDF
Original articles
Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gunia S, Koch S, May M
Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?
Journal of Clinical Pathology 2013;66:109-112.